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   The concentration of zinc （Zn）， iron （Fe） and copper （Cu） as trace rnetals in the trace
elements， as well as magnesium （Mg）’and calcium （Ca）， in the excised tumor tissue， serum
and urine of the patients with urinary bladder tumot was measured by using atornic absorption
spectrophotometer． The results obtained are as follows．
   1） The specimens taken from the tumor generally indiacated increase of Zn and Mg
content with decrease of Cu’content in comparison with those taken from the norma／ blad－
der rnucosa． Same was found between the tumor tissue and thenormal muco a taken from
same individuals．
   2） lncrease of Fe and Zn content in the papillary turnor was found， while．decrease
of Cu．．c6htent was．曲ow血in the in飢trative tumor． Papillary carcino皿a seemed to show
higher content of Zn than the cancer of other histopathological types．
   3） No meaningful differeAce was observed between the metal content and histopatholo－
gical malignancies， ’?盾翌?魔?秩C decrease of Cu in stage Bi to D and increase of Ca・ in stage O
to A were confirmed．
   4） Decrease of seru’m Fe in the patients of bladder tumor was prominent in comparison
with healthy subjects and patients who had removal of tumor．
   5） ’The patients of bladder tumor with anemia showed， in general， tendency of decrease
qf．．．Zn and．．e6～and of i準crease of． CU co皿pared． with the patients輌thout ariemia． Content of．
Zn and Fe returned to normal a．ccording to improvement of anemia following operations．
   6） ’ Decrease of Zn and Fe whsi showri in the pati’e’nts bearing tumor with hypoproteine－
rp．．． ia，．ho／．i＞vev．er，．／lno．t． higg．．w． as telated to A／G rati．Ql ．
   7） T． he patie．nts of bladde．r tu． rnor seqrped to excrete more Fe and less Mg into the urine
than． healthy ’subjects． ’
   8） ．Turbid urine sample revealed increase of Fe and Ca， while clear urihe sample show－
ed dectea’se of Mg．
   ，9），．Afi． er c g．cu！S．．b． IQod i．p．． ．the．urine pf the． patients．with bladqer tumor was examined， the
supetnatdnt was uSed’ for the’ Sttidy． lncrease of Zn and Fe contenf irt the urine with occult
blood was demonstrated． Zn・content increased when th’?amount of occult blood in the urine
reached a mediu．m degree． lncre，ase of Zn．and Ca content was proved when the amount of
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 Table 1の1， Fig．1に示すように全般的に膀胱腫
瘍の37例と健常膀胱粘膜の22例を比較すると，健常
粘膜では，Zn， Mg， Fe， Cu， Caの順に，それぞれ
ll．450±13．745， 26．820±8．505， 1．788±O．877， O．417±
0．190，19、266±8．541 mcg／g湿重量で，腫瘍では22．






9．206， L797±O．927， O．411±O．207， 20．278±8．523
mcg／g湿重量で，腫瘍は22．791±14．745，86．247±






















































































Fig． 2． Trace rnetals of bladder tumors and bladder mucosa in individua1 patients．




（Table 1のIII， Fig．3），前者ではZn， Mg， Fe，
Cu， Caの順に，それぞれ20．337±15，499，89，292±
38．620， 1．518±O．764， O．221±O．060， 20．882±10．879
mcg／g湿重量で，後者では24．450±14．呂16，76．160±：







Zn， Mg， Fe， Cu， Caの順にそれぞれ27．249±16．430，
85．396±33．868， 2．173±1．053， O．289±O．205， 24．855±
．850mcg／9湿重量で，後者の群は，ユ2．934±6．297，
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Fig． 6． Trace metals of Stage O－A and Stage B－D carcinoma of the bladder． （mcg／g wet weight）
Stage O－A群の19例とStage BrD群の11例に分け
て比較してみると（Table 1のVI， Fig・6）， Stage
O－A群ではZn， Mg，．Fe， Cu， Caの順にそれぞれ






































 対照の健康人15例の血清値は，Zn， Mg， Fe， Cu， Ca
の順にそれぞれ107．400±28．872mcg／dL 1．880±
O．364mg／dl，・ 127．320±11．944 mcg／dl， 105．603±
10．480mcg／d1，10．547±0．879 mg／d1であり，膀胱腫
瘍の坦三者の36例は，それぞれ100．787±28．152mcg／




±O．391mg／dl， 116．671±18．600 mcgfdl， 102．013±
22．810 mcg／dl，10．566±0．867mg／dlであった（Ta－








2．098±O．502mg／dl， 73．825±20．629 mcg／dL 136．880
±20．788mcg／dl，11。156±0．653 mg／d1であり，貧血
のない群はそれぞれ120．015±19．309mcg／dl；2．028







Table 2． Serum materials （rnean with standard deviation）．
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はZn， Mg， Fe， Cu， Caの順にそれぞれ87．947±
21．310mcg／dL 2：097±O．502 mg／dl， 86．882±29．611
mcg／dl， 114．420±24．848 mcg／dl， 11．071±O．621 mg／
dlであり，’後者はそれぞれ113．183±：29．080 mcg／d1，
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11．579mcg／dl， 6．426±1．290 mg／dl， 3．269±1．361
mcg／dl， 1．002±0．358 mg／dlであり，腫瘍摘除後の
者32例の尿ではそれぞれ43．622±11．346mcg／dl，









±1．259mg／dl， 3．937±1，385 mcg／dl， 1．168±O．300
mg／dlであり，後者ではそれぞれ45．621±6，507






ある群ではZn， Mg， Fe， Caの順にそれぞれ55．933

















                   Table 3． Urine materials（mean with standard deviation）．
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